Skip to main content
. 2010 Jul 7;16(5):e138–e156. doi: 10.1111/j.1755-5949.2010.00185.x

Figure 1.

Figure 1

Constructs of the fluorescent protein fusion genes used for transgenic animal models. (A) Structure of the arginine vasopressin (AVP)‐enhanced green fluorescent protein (eGFP) transgene. In the AVP‐eGFP transgene, the eGFP coding region is inserted at the frame in the middle of exon III. “Copyright 2005, The Endocrine Society” modified and reproduced with permission from Ref. [94]. (B) Structure of the c‐fos‐monomeric red fluorescent protein 1 (mRFP1) transgene. In the c‐fos‐mRFP1 transgene, the mRFP1 coding region is inserted at the frame at the end of exon IV followed by the stop codon. “Copyright 2009, The Endocrine Society” reproduced with permission from Ref. [98]. (C) Structure of the oxytocin‐enhanced cyan fluorescent protein (eCFP) transgene. In the oxytocin‐eCFP transgene, the eCFP coding region is inserted at the frame in the middle of exon III, after the oxytocin and the bulk of the neurophysin coding regions. “Copyright 2010, Society for Endocrinology” modified and reproduced with permission from Ref. [97].